Streptococcus Pneumoniae
Streptococcus Pneumoniae - Related Videos
04:46
Intrabronchial Instillation of Streptococcus pneumoniae in Immunocompetent Rodent Models
0 Views •
2025
This video demonstrates the establishment of lung infection in an immunocompetent rodent model via intubation and installation of bacterial suspensions into lung lobes. This model enables antibacterial efficacy studies in immunocompetent animals.
04:25
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
0 Views •
Cited by 86 •
2014
The Quellung reaction is the gold standard technique for serotyping Streptococcus pneumoniae. This technique utilizes a microscope and specific pneumococcal antisera and is commonly used in reference and research laboratories worldwide.
09:11
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
0 Views •
Cited by 32 •
2014
Latex agglutination testing is a simple, rapid and inexpensive method for serotyping Streptococcus pneumoniae, and has also been widely applied in diagnostic microbiology. This manuscript describes the in-house production of latex agglutination reagents, quality control procedures and the application of this technique to pneumococcal serotyping.
09:12
Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
0 Views •
Cited by 27 •
2014
Colonization of the murine nasopharynx with Streptococcus pneumoniae and the subsequent extraction of adherent or recruited cells is described. This technique involves flushing the nasopharynx and collection of the fluid through the nares and is adaptable for various readouts, including differential cell quantification and analysis of mRNA expression in situ.
03:17
A Mouse Model to Study the Pathogenic Transition of Streptococcus pneumoniae Following Viral Co-Infection
0 Views •
2026
Source: Lenhard, A. et al. A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness. J. Vis. Exp. (2022)This video demonstrates a mouse co-infection model in which the influenza virus triggers the transition of Streptococcus pneumoniae from a colonizer to a pathogen. It outlines the steps involved in bacterial colonization, viral infection, and disease progression.
FAQs
The polysaccharide capsule helps Streptococcus pneumoniae evade phagocytosis, a host defense process in which immune cells engulf and destroy microbes. By reducing the effectiveness of this clearance mechanism, the capsule can support bacterial survival during colonization and infection. Its role makes capsule biology an important focus when researchers investigate pneumococcal virulence and interactions with host immunity.
Progression from upper respiratory tract carriage to invasive disease reflects a shift from relatively localized colonization to infection of deeper or normally protected sites. Transmission through respiratory droplets can establish carriage, while bacterial virulence factors and interactions with host immunity influence whether disease develops. Studying this transition helps explain why outcomes can range from asymptomatic carriage to severe illness.
Virulence factors are bacterial features that influence the ability to survive in the host, evade immune defenses, and contribute to disease. For Streptococcus pneumoniae, examining these factors alongside the capsule helps researchers connect bacterial properties with outcomes such as pneumonia, meningitis, sinusitis, or otitis media. This knowledge supports investigation of pathogenesis and potential treatment or prevention strategies.
Researchers examine interactions between Streptococcus pneumoniae and host immunity to determine how immune defenses respond to the bacterium and how bacterial features affect that response. This work complements studies of virulence factors and antibiotic resistance, creating a broader picture of pathogenesis. The resulting biological insight can guide the development and evaluation of vaccines, diagnostic methods, and treatments.
Research on Streptococcus pneumoniae supports vaccines designed to reduce severe disease and transmission. Because the bacterium can spread through respiratory droplets and may be carried without symptoms, prevention has relevance beyond treating individual infections. Vaccine evaluation therefore connects bacterial biology with public health goals, including limiting progression to invasive disease and reducing opportunities for transmission.
Antibiotic resistance can affect how pneumococcal disease is treated, making it important to monitor alongside virulence and host immune interactions. Researchers study resistance to understand its contribution to treatment challenges and to inform the evaluation of therapies. This work is especially relevant because Streptococcus pneumoniae can cause several clinically important conditions, including invasive disease requiring effective medical management.